The current study of Japanese patients with MS disclosed that HLA-DRB1*15 was associated with low anti-JCV antibody positivity and low antibody index, and that in the absence of DRB1*15, DRB1*04 carriers were associated with high antibody seropositivity. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.